These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37259867)

  • 21. Pathogenic and therapeutic roles of cytokines in acute myeloid leukemia.
    Karimdadi Sariani O; Eghbalpour S; Kazemi E; Rafiei Buzhani K; Zaker F
    Cytokine; 2021 Jun; 142():155508. PubMed ID: 33810945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of cellular senescence-related signature for predicting prognosis and therapeutic response of acute myeloid leukemia.
    Zhong F; Yang Y; Yao F; Liu J; Yu X; Wang XL; Huang B; Wang XZ
    Aging (Albany NY); 2023 Oct; 15(20):11217-11226. PubMed ID: 37845004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The stimulator of interferon genes (STING) agonists for treating acute myeloid leukemia (AML): current knowledge and future outlook.
    Song X; Peng Y; Wang X; Chen Q; Lan X; Shi F
    Clin Transl Oncol; 2023 Jun; 25(6):1545-1553. PubMed ID: 36587109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
    Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
    Front Immunol; 2021; 12():695865. PubMed ID: 34135913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel therapeutic strategy: the significance of exosomal miRNAs in acute myeloid leukemia.
    Salehi A
    Med Oncol; 2024 Jan; 41(2):62. PubMed ID: 38253748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aging-related genes related to the prognosis and the immune microenvironment of acute myeloid leukemia.
    Gang D; Jiang Y; Wang X; Zhou J; Zhang X; He X; Dong R; Huang Z; Jiang S
    Clin Transl Oncol; 2023 Oct; 25(10):2991-3005. PubMed ID: 37067728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia.
    Wang J; Hao JP; Uddin MN; Wu Y; Chen R; Li DF; Xiong DQ; Ding N; Yang JH; Ding XS
    Aging (Albany NY); 2021 Jun; 13(12):16445-16470. PubMed ID: 34148032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
    Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
    Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
    [No Abstract]   [Full Text] [Related]  

  • 29. Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemia.
    Zhong FM; Yao FY; Liu J; Li MY; Jiang JY; Cheng Y; Xu S; Li SQ; Zhang N; Huang B; Wang XZ
    J Transl Med; 2023 Jan; 21(1):6. PubMed ID: 36611187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
    Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
    Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNAs: A novel insight in the leukemogenesis and drug resistance in acute myeloid leukemia.
    Kirtonia A; Ashrafizadeh M; Zarrabi A; Hushmandi K; Zabolian A; Bejandi AK; Rani R; Pandey AK; Baligar P; Kumar V; Das BC; Garg M
    J Cell Physiol; 2022 Jan; 237(1):450-465. PubMed ID: 34569616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Performing integrative transcriptomic and chemical screening to identify patient-specific vulnerabilities in poor-prognosis acute myeloid leukemia].
    Hashimoto M; Ishikawa F
    Rinsho Ketsueki; 2021; 62(7):774-780. PubMed ID: 34349062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CircRNF220, not its linear cognate gene RNF220, regulates cell growth and is associated with relapse in pediatric acute myeloid leukemia.
    Liu X; Liu X; Cai M; Luo A; He Y; Liu S; Zhang X; Yang X; Xu L; Jiang H
    Mol Cancer; 2021 Oct; 20(1):139. PubMed ID: 34702297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.
    Carter BZ; Mak PY; Wang X; Tao W; Ruvolo V; Mak D; Mu H; Burks JK; Andreeff M
    Cancer Res; 2019 Mar; 79(6):1165-1177. PubMed ID: 30674535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute Myeloid Leukemia Cells Educate Mesenchymal Stromal Cells toward an Adipogenic Differentiation Propensity with Leukemia Promotion Capabilities.
    Zhang L; Zhao Q; Cang H; Wang Z; Hu X; Pan R; Yang Y; Chen Y
    Adv Sci (Weinh); 2022 Jun; 9(16):2105811. PubMed ID: 35686138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
    Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
    Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression.
    Zhang J; Peng Y; He Y; Xiao Y; Wang Q; Zhao Y; Zhang T; Wu C; Xie Y; Zhou J; Yu W; Lu D; Bai H; Chen T; Guo P; Zhang Q
    Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166268. PubMed ID: 34536536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunorelated gene polymorphisms associated with acute myeloid leukemia.
    Liu Q; Hua M; Yan S; Zhang C; Wang R; Yang X; Han F; Hou M; Ma D
    Clin Exp Immunol; 2020 Sep; 201(3):266-278. PubMed ID: 32349161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia.
    Sun YX; Kong HL; Liu CF; Yu S; Tian T; Ma DX; Ji CY
    Hum Immunol; 2014 Feb; 75(2):113-8. PubMed ID: 24269703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AML.
    Masarova L; Kantarjian H; Garcia-Mannero G; Ravandi F; Sharma P; Daver N
    Adv Exp Med Biol; 2017; 995():73-95. PubMed ID: 28321813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.